logo
Oral Cancer Cases Are on The Rise, And Sugary Drinks Could Be to Blame

Oral Cancer Cases Are on The Rise, And Sugary Drinks Could Be to Blame

Yahoo27-03-2025

It may not just be tooth decay you need to worry about when it comes to sugary drinks: new research suggests that these sweetened beverages might also be raising the risk of oral cancer.
Researchers from the University of Washington crunched the numbers from a public health database, looking at records covering the dietary habits of 162,602 women, 124 of whom developed oral cancer over a 30-year period.
Compared with women who drank less than one sugary drink per month, those who indulged in one or more sugary drinks daily were 4.87 times more likely to develop oral cancer.
Those who didn't drink alcohol or smoke much or at all, but consumed one or more sugary drinks daily, were at 5.46 times higher risk of oral cancer than women who drank less than one sugary drink each month.
"The incidence of oral cavity cancer (OCC) is increasing among non-smokers and young individuals without traditional risk factors worldwide," write the researchers in their published paper.
"In this study, high sugar-sweetened beverage intake was associated with a significantly increased risk of OCC in women, regardless of smoking or drinking habits, yet with low baseline risk."
The structure of this study means it does not show direct cause and effect, because other factors may be involved that the researchers haven't accounted for. However, the association is strong enough to suggest there is some relationship here.
Traditionally, oral cancer is linked to risk factors such as smoking or chewing tobacco, drinking heavily, and human papillomavirus (HPV) infection. It's a real concern that oral cancer cases are quickly rising outside of these risk factors.
One reason that's been put forward for this is our changing dietary habits. The unhealthy foods many of us are now consuming on a regular basis could be triggering long-term inflammatory responses from the body's immune system.
"A Western dietary pattern has increasingly been recognized as a risk factor for gastrointestinal tract cancers and is characterized by high consumption of saturated fats, processed foods, and added sugars," write the researchers.
"Our hypothesis is that diets with higher added sugar may contribute to chronic inflammation, which may, in turn, contribute to the risk of OCC."
There are some limitations here – the study only looked at data for women, and covers a relatively low number of cancer cases – and the researchers are keen for more data to be collected and assessed on this potential link.
However, it's another compelling reason for us to watch what we drink as well as what we eat. The health dangers associated with sugary drinks aren't new, but we're now realizing just how harmful they can be.
"The methodology and quality of the study are excellent and the data has been analysed in great detail," says epidemiologist Raúl Zamora Ros, from the Catalan Institute of Oncology (ICO) in Spain, who wasn't involved in the research.
"More studies are needed to confirm these associations and also to assess whether soft drinks with artificial sweeteners would be just as harmful, as many people substitute one for the other."
The research has been published in JAMA Otolaryngology – Head & Neck Surgery.
Chewing Gum Releases Hundreds of Microplastics In Your Mouth, Study Finds
Clearing Brain Waste Dramatically Improves Memory in Aging Mice
Night Owls Face Higher Depression Risk. A New Study Explains The Link.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Influencer Tanner Martin dead at 30 of colon cancer — this was his first symptom
Influencer Tanner Martin dead at 30 of colon cancer — this was his first symptom

New York Post

time8 hours ago

  • New York Post

Influencer Tanner Martin dead at 30 of colon cancer — this was his first symptom

Utah-based influencer Tanner Martin, who died this week of colon cancer at the age of 30, said his five-year battle began with a single symptom. Martin was diagnosed with the disease, which occurs when cells in the colon grow out of control, in 2020 at the age of 25. While colon cancer is traditionally linked to older adults, diagnoses among younger people have skyrocketed in recent years. 4 Tanner Martin was diagnosed with colon cancer in 2020 at the age of 25. The Washington Post via Getty Images Oncologists have suggested that the concerning rise in youth cases and deaths could be due to obesity, a sedentary lifestyle, the Western diet, excess sugar consumption and environmental factors such as pollutants in the air, soil and water. The exact causes are still unclear. Martin's first symptom was a mild but persistent stomachache that began in 2020. He said that the pain was not debilitating but made him feel unwell. Gastrointestinal medical oncologist Benny Johnson notes that some 15% of colon cancer patients report abdominal pain, described as an 'intermittent crampy feeling.' Martin then began experiencing severe constipation. 4 Though colorectal cancer can sometimes be asymptomatic, a change in bowel habits or caliber of stool — as well as rectal bleeding or weight loss — are among the most common symptoms. M+Isolation+Photo – Though colon cancer can sometimes be asymptomatic, a change in bowel habits or stool — as well as rectal bleeding or weight loss — are among the classic symptoms. Experts maintain that constipation now and then isn't a cause for concern, but if you're normally regular — and then you're stopped up for weeks or months at a time — that's not normal and could be a sign that cancer is obstructing your bowels. 'If you notice persistent diarrhea, constipation or a change in the shape, size, consistency or frequency of your stool, don't simply brush it off as stress or diet changes,' Dr. Cedrek McFadden, a colorectal surgeon based in South Carolina and medical adviser to the Colorectal Cancer Alliance, previously told The Post. Also watch for fatigue. A low red blood cell count, known as anemia, is present in 30% to 75% of colorectal cancer patients and can contribute to feelings of exhaustion. Despite Martin's telltale symptoms, his initial bloodwork was normal, and it took six months for a specialist to recommend him for a colonoscopy. 4 Despite Martin's telltale symptoms, his bloodwork was normal, and it took six months for a specialist to recommend him for a colonoscopy. Instagram / tannerandshay Because of the rise in younger cases, the US Preventive Services Task Force updated its colorectal cancer screening guidelines in 2021 to lower the recommended age to start screening from 50 to 45 for adults at average risk. By the time Martin underwent the procedure, doctors discovered that the cancer had spread from his colon to his liver. He was given a Stage 4 terminal diagnosis. According to the Washington Post, young people like Martin, who are of Native American descent, have the highest rate of colorectal cancer of any racial and ethnic group. Despite his grim prognosis, Martin finished college and found a job, but the fatigue from his treatments and the toll of five surgeries made it impossible for him to work. He began documenting his cancer journey on TikTok and Instagram, where his candor and optimism made him a viral sensation. 4 In 2024, in light of what appeared to be an effective treatment, Martin and Shay decided to start a family. The Washington Post via Getty Images Martin and his wife, Shay, also started the nonprofit Rebels Against Cancer. Martin, who had always dreamed of being a father, banked his sperm shortly after his diagnosis, as infertility is a common side effect of chemotherapy. In 2024, in light of what appeared to be an effective treatment for Martin, he and Shay decided to start a family. However, by 2025, Martin's condition had taken a turn for the worse, spreading to his lymph nodes, and he was uncertain whether he would live long enough to meet his daughter. He and Shay welcomed Amy Lou on May 15. Martin announced his untimely passing in a prerecorded video shared by Shay on Wednesday. He wanted to record a 'lighthearted' video ahead of his death so Shay could upload it and focus on grieving. Martin, who did not have life insurance, also recorded a separate video in which he shared that his dying wish was for fans to donate to his widow and newborn daughter through a GoFundMe fundraiser, 'to help replace what I would be there for.' 'For less than the price of a hot and spicy McChicken (Tanner's words…LOL), you can give them a future Tanner only wished he could stay to provide,' the page said. The fundraiser has raised over $500,000 so far.

In surprise move, RFK Jr.'s vaccine committee votes to recommend RSV shot for infants
In surprise move, RFK Jr.'s vaccine committee votes to recommend RSV shot for infants

USA Today

time9 hours ago

  • USA Today

In surprise move, RFK Jr.'s vaccine committee votes to recommend RSV shot for infants

In their first vote since appointed by Health and Human Services Secretary Robert F. Kennedy Jr., the eight members of a vaccine committee voted to recommend a shot that protects infants against respiratory syncytial virus, or RSV. Clesrovimab, a monoclonal antibody created by pharmaceutical giant Merck, is recommended for use in infants younger than eight months born during or entering their first RSV season. Martin Kulldorff, who led the June 26 meeting, recently served as an expert witness for plaintiffs who accused Merck of concealing the risks of Gardasil, a vaccine used to prevent cancer from human papillomavirus, or HPV. The eight new ACIP members met for the first time on June 25. Kennedy fired all 17 original members of the committee on June 9 and appointed its new members a few days later. Given the inclusion of vaccine skeptics, the approval comes as a surprise to close watchers of the panel. Experts from the Centers for Disease Control and Prevention's workgroup that presented data on the drug universally supported the drug. However, two panel members still voted against it. RSV infects nearly everyone by the time they're 2. It causes cold symptoms, affecting the breathing passages and lungs, according to the CDC. In the U.S., about 58,000 children younger than 5 are hospitalized for RSV each year, and several hundred die. ACIP's first meeting: Inside the unusual, RFK-appointed panel that's deciding on childhood vaccines Merck's shot is the second RSV monoclonal antibody on the market. The first, a shot from Sanofi and AstraZeneca called Beyfortus, was approved by the Food and Drug Administration in July 2023 and prevents RSV lower respiratory tract disease in infants entering or during their first RSV season. It was the first of its kind to be widely available to everyone beyond a small population of immunocompromised children. Data presented during the June 25 ACIP meeting found the shot reduced hospitalizations by about 47% in newborns up to two months old, the population at highest risk of hospitalization. Dr. Cody Meissner, who voted to recommend the Merck shot, said on June 25 that the result data from Beyfortus in the last RSV season was an 'astonishing accomplishment.' The Beyfortus shot was recommended by ACIP in 2023 for babies under 9 months old who are entering their first RSV season. It's also recommended for babies 8 to 19 months who are at increased risk of severe disease if they're entering their second season of RSV. Parents will have the choice between the two shots. If they receive Beyfortus, they're not recommended to get the new monoclonal antibody by Merck. Pregnant patients also have access to Pfizer's RSV vaccine Abrysvo, which is recommended for pregnant people to protect newborns from lower respiratory infections. The shot is approved for use during the 32nd and 26th weeks of pregnancy during the RSV season, which typically starts in September and runs through January in the U.S. Adrianna can be reached at adrodriguez@

In surprise move, RFK Jr.'s vaccine committee votes to recommend RSV shot for infants
In surprise move, RFK Jr.'s vaccine committee votes to recommend RSV shot for infants

Yahoo

time9 hours ago

  • Yahoo

In surprise move, RFK Jr.'s vaccine committee votes to recommend RSV shot for infants

In their first vote since appointed by Health and Human Services Secretary Robert F. Kennedy, the eight members of a vaccine committee voted to recommend a shot that protects infants against respiratory syncytial virus, or RSV. Clesrovimab, a monoclonal antibody created by pharmaceutical giant Merck, is recommended for use in infants younger than eight months born during or entering their first RSV season. Martin Kulldorff, who led the June 26 meeting, recently served as an expert witness for plaintiffs who accused Merck of concealing the risks of Gardasil, a vaccine used to prevent cancer from human papillomavirus, or HPV. The eight new ACIP members met for the first time on June 25. Kennedy fired all 17 original members of the committee on June 9 and appointed its new members a few days later. Given the inclusion of vaccine skeptics, the approval comes as a surprise to close watchers of the panel. Experts from the Centers for Disease Control and Prevention's workgroup that presented data on the drug universally supported the drug. However, two panel members still voted against it. RSV infects nearly everyone by the time they're 2. It causes cold symptoms, affecting the breathing passages and lungs, according to the CDC. In the U.S., about 58,000 children younger than 5 are hospitalized for RSV each year, and several hundred die. ACIP's first meeting: Inside the unusual, RFK-appointed panel that's deciding on childhood vaccines Merck's shot is the second RSV monoclonal antibody on the market. The first, a shot from Sanofi and AstraZeneca called Beyfortus, was approved by the Food and Drug Administration in July 2023 and prevents RSV lower respiratory tract disease in infants entering or during their first RSV season. It was the first of its kind to be widely available to everyone beyond a small population of immunocompromised children. Data presented during the June 25 ACIP meeting found the shot reduced hospitalizations by about 47% in newborns up to two months old, the population at highest risk of hospitalization. Dr. Cody Meissner, who voted to recommend the Merck shot, said on June 25 that the result data from Beyfortus in the last RSV season was an 'astonishing accomplishment.' Beyfortus shot that was recommended by ACIP in 2023 for babies under 9 months old who are entering their first RSV season. It's also recommended for babies 8 to 19 months who are at increased risk of severe disease if they're entering their second season of RSV. Parents will have the choice between the two shots. If they receive Beyfortus, they're not recommended to get the new monoclonal antibody by Merck. Pregnant patients also have access to Pfizer's RSV vaccine Abrysvo, which is recommended for pregnant people to protect newborns from lower respiratory infections. The shot is approved for use during the 32nd and 26th weeks of pregnancy during the RSV season, which typically starts in September and runs through January in the U.S. Adrianna can be reached at adrodriguez@ This article originally appeared on USA TODAY: RFK Jr.'s new ACIP votes to recommend RSV shot for infants

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store